A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled Diranersen (BIIB080) Co-administered With Diranersen in Healthy Adults
Clinical trial NCT06454721 · COMPLETED
Trial details
- NCT number
- NCT06454721
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-30
- Primary completion
- 2026-03-05
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.